GlassScriptPhysician profile
Michael David Scheiber
NPI 1578590667
$163,806.16
in general payments reported to CMS, 2019-2025
18 companies · $25K in 2025
The $25K reported for 2025 was more than what 99% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $21K · 2021: $13K · 2022: $27K · 2023: $55K · 2024: $7,600 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Consulting Fee: $27K · Travel and Lodging: $7,356 · Food and Beverage: $4,658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,507.50 |
| Consulting Fee | $27,457.50 |
| Travel and Lodging | $7,356.25 |
| Food and Beverage | $4,658.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $118,583.66 | 2019-2025 | Menopur |
| Hologic Sales and Service, LLC | $16,202.85 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Ferring INC. | $13,226.85 | 2025 | Menopur |
| Ferring International Center Sa | $5,738.75 | 2021 | |
| Ferring Pharmaceuticals Sa Rep Office Middle East | $3,000.00 | 2020 | |
| Coopersurgical, INC. | $1,772.38 | 2019-2025 | Stripper, Origio Sequential Fert |
| Cytyc Surgical Products, LLC | $1,377.25 | 2024-2025 | Myosure Tissue Removal Device, Acessa Provu System, None |
| Merck Sharp & Dohme LLC | $1,125.00 | 2020 | |
| Gynesonics, INC. | $1,104.32 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Emd Serono, INC. | $965.66 | 2019-2025 | |
| Therapeuticsmd, INC. | $204.12 | 2019 | |
| Organon LLC | $163.26 | 2023-2024 | Ganirelix Acetate, Pregnyl, Follistim Aq |
| Meditrina | $143.29 | 2025 | |
| Abbvie INC. | $136.05 | 2019 | |
| Cook Medical LLC | $49.46 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $13.26 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scheiber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.